Ligand Pharmaceuticals Inc (LGNZZ) — DEFA14A Filings
All DEFA14A filings from Ligand Pharmaceuticals Inc. Browse 2 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (2)
-
Ligand Pharma Files Proxy Materials
— Jun 3, 2024 Risk: low
Ligand Pharmaceuticals Inc. filed a Definitive Additional Materials (DEFA14A) on June 3, 2024, related to its proxy statement. The filing indicates no fee was r -
Ligand Pharma Files Proxy Supplement
— May 9, 2024 Risk: low
Ligand Pharmaceuticals Inc. filed a Definitive Additional Materials filing (DEFA14A) on May 9, 2024, supplementing its proxy statement for the annual meeting. T
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX